3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
55
Endometrial Neoplasms
7
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Polycystic Ovary Syndrome
4
Neoplasms
4
Advanced Breast Cancer
4
Triple Negative Breast Neoplasms
3
Prostatic Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
3
Recurrence
2
Neoplasms by Site
2
Infertility
2
HR+/HER2- Breast Cancer
2
Estrogen Receptor-positive Breast Cancer
2
Carcinoma, Non-Small-Cell Lung
2
Breast Neoplasms, Male
2
Breast Diseases
2
Uterine Cervical Neoplasms
1
Unilateral Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Sexual Dysfunctions, Psychological
1
Pathologic Complete Response
1
Pancreatic Neoplasms
1
Low-Grade Serous Ovarian Cancer
1
Low Grade Serous Ovarian Carcinoma
1
Low Grade Serous Ovarian Cancer
1
Locoregional Recurrence
1
Leiomyoma
1
Interventions
Magnetic Resonance Spectroscopy
3
Steroids
2
Specimen Handling
2
Hormones
2
Cyclin-Dependent Kinase Inhibitor p18
2
Cyclin-Dependent Kinase Inhibitor p16
2
Biopsy
2
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
taxane
1
radium Ra 223 dichloride
1
pertuzumab
1
abemaciclib
1
X-Rays
1
Trastuzumab
1
Taxoids
1
Taxes
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Photons
1
Paclitaxel
1
PF-05280014
1
Ontruzant
1
Ogivri
1
Mastectomy, Simple
1
Mastectomy, Segmental
1
High-Energy Shock Waves
1
Capecitabine
1
CT-P6
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anatomic Stage IV Breast Cancer AJCC v8
×
Letrozole
×
90 days
×
Clear all
No trials found.